POSTER SESSION VI Wednesday, March 26, 2003   —  1:00 - 4:00 PM Exhibit Hall A - C GYNECOLOGIC PATHOLOGY 104 Cyclin E Amplification and hCdc4 Mutation Analysis in Endometrial Carcinoma (929) J Palacios, R Cassia, G Moreno-Bueno, S Rodriguez-Perales, D Hardisson, JC Cigudosa Centro Nacional de Investigaciones Oncologicas, Madrid; Hospital La Paz, Madrid, Spain 105 Association of Altered PTEN Expression and Upregulation of Phospho Akt in Uterine Endometrioid Adenocarcinoma (953) DS Rush, H Wang, W Douglas, LH Ellenson Weill Medical College of Cornell University, New York, NY 106 Focal Adhesion Kinase Overexpression in Endometrial Neoplasia (907) CA Livasy, J Sciarrotta, CT Rajaratnam, WG Cance, RA Lininger University of North Carolina, Chapel Hill, NC; Widener University, Chester, PA 107 MMP-3, MMP-7, MMP-9 Expression in Endometrial Carcinoma (978) JJ Xiong, JW Mercurio, CE Sheehan, S Petrocine, RA Ambros, JS Ross Albany Medical College, Albany, NY 108 Alteration of BAX and p53 Expression in the Histologic Subtypes of Endometrial Carcinomas and Uterine Malignant Mixed Mesodermal Tumors (816) AJ Ali, JJ Xiong, CE Sheehan, H Xu, RA Ambros, JS Ross Albany Medical College, Albany, NY 109 Malignant Mixed Mullerian Tumors of the Female Genital Tract: A Clinicopathologic Study of 27 Cases (947) IM Rodriguez, S Bague, J Prat Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Spain 110 Subclassification of Malignant Mixed Mullerian Tumors (Carcinosarcoma) with the p53 Homologue p63 (876) MS Hirsch, MR Nucci, JL Hecht, A Cviko, CP Crum Brigham and Women's Hospital; Beth Israel Deaconess Medical Center, Boston, MA 111 CD117 and CD34 Expression by Immunohistochemistry in Uterine Malignant Mixed Mullerian Tumors (850) M Constantinescu, EA Turbat-Herrera, ML Nordberg, W Daley, L Jones, R Mansour, GA Herrera Louisiana State University Health Sciences Center, Shreveport, LA; University of Mississippi Medical Center, Jackson, MS; Shreveport, LA; Overton Brooks VA Medical Center, Shreveport, LA 112 Extrauterine Mullerian Adenosarcomas: A Clinicopathologic Study of 24 Cases (826) BL Balzer, MR Hendrickson Stanford University Medical Center, Stanford, CA 113 Uterine Leiomyosarcomas in Patients under 45 Years of Age: A Clinicopathologic Study of 46 Cases (913) CC McNeese, EG Silva, MT Deavers, A Malpica University of Texas Medical School at Houston, Houston, TX; UT-MD Anderson Cancer Center, Houston, TX 114 Distinction of Endometrial Stromal Neoplasms from Cellular Leiomyomas Using CD10, Smooth Muscle Myosin, and H-Caldesmon Immunohistochemical Stains (891) A Kolareth, MA Vasef, JA Benda University of Iowa, Iowa City, IA 115 Lack of Interaction with the EZH2 Polycomb Group Complex Distinguishes the JAZF1-JJAZ1 Fusion Protein Associated with Endometrial Stromal Tumors from Normal JJAZ1 (899) NI Lindeman, P Mittal, JI Koontz, JD Parvin, JL Sklar Brigham and Women's Hospital, Harvard Medical School, Boston, MA 116 Detection of t(7;17) in Endometrial Stromal Neoplasia by RT-PCR and FISH (923) MR Nucci, J Koontz, P Pauwels, J Sklar Brigham and Women's Hospital, Boston, MA; Stichting PAMM, Eindhoven, Netherlands 117 CD10 Expression in Cycling Endometrium and Decidua (982) F Yamasaki, K Tungsinmunkong, OB Ioffe, SG Silverberg University of Maryland, Baltimore, MD 118 Changes in Endometrial Survivin Expression throughout Menstrual Cycle and in Early Gestational Endometrium (956) BZ Senturk, M Berkkanoglu, V Parkash, HH Yu, W Zheng Yale Univeristy School of Medicine; Yale University School of Epidemiology and Public Health, New Haven, CT 119 Levonorgestrel Releasing Intrauterine Device. Clinicopathological Correlation (958) HP Sevestre CHU Amiens, Amiens, France 120 Endometrial "v$3 Integrin Expression and Pinopode Formation in Women Receiving Contraceptive Therapy or Ovulation Induction (927) J Ordi, M Creus, B Ferrer, F Fabregues, F Carmona, R Casamitjana, A Cardesa, J Balasch IDIBAPS-Hospital Clinic, University of Barcelona, School of Medicine, Barcelona, Spain 121 Uterine Adenomyosis, Complete and Incomplete (830) M Black, R Ali, A Stringer, MT Deavers, A Malpica, EG Silva Baylor University, Dallas, TX; Wayne State University, Detroit, MI; M. D. Anderson Cancer Center, Houston, TX 122 Incidence of Hydatidiform Mole (HM): A 12-year (1989-2000) Prospective Morphological and Flow Cytometric Study (863) M Fukunaga Jikei University, Tokyo, Japan 123 Immunohistochemical Study of p57 in Intermediate Trophoblastic Lesions (880) M Jalali, A Malpica, MT Deavers, T Burke, EG Silva UT-Houston Medical School, Houston, TX; MD Anderson Cancer Center, Houston, TX 124 p27KIP1 and Cyclin E Expression in Early Hydatidiform Moles (862) M Fukunaga Jikei University, Tokyo, Japan 125 Is Classifying Molar Gestations into Partial and Complete Clinically Relevant? An Outcome Appraisal (949) RL Romaguera, MM Rodriguez, T Zuluaga, MA Penalver, M Nadji University of Miami/Jackson Memorial Medical Center, Miami, FL 126 Immunohistochemical Detection of Glucose Transporter GLUT1 in Benign and Malignant Fallopian Tube Epithelia (884) TL Kalir, RI Demopoulos, J Rahaman, CJ Cohen, DE Burstein Mount Sinai School of Medicine, New York, NY; NYU Medical Center, New York, NY 127 Characteristics of Vascular Structure of Molar Villi in Complete Hydatidiform Mole (985) K Yoshida, T Nagasaka, N Nakashima Hekinan Municipal Hospital, Hekinan, Aichi, Japan; Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan 128 Immunohistochemical Profile of Gynecologic Neoplasms with an Emphasis on Fallopian Tube and Serous Carcinomas (881) KD Jewell, PE Swanson, RL Garcia, SN Agoff University of Washington Medical Center, Seattle, WA 129 VEGF- , KIT Protein- , and Neutral Endopeptidase (NEP / CD10)-Positive Spindle-Cell-Shaped Myofibroblasts - Precursors of Angiogenesis in Chorioangiomas? (921) F Noack, K Sotlar, C Thorns, J Smrcek, K Diedrich, AC Feller, H-P Horny Medical University of Luebeck, Luebeck, Germany; University of Tuebingen, Tuebingen, Germany